Evolva is a Swiss biotech company focused on the research, development and commercialisation of ingredients based on nature. It has leading businesses in flavours and fragrances, health ingredients and health protection. Evolva’s proprietary fermentation-based technology allows for the large-scale production of ingredients that would otherwise be prohibitively expensive. Over the past few years, Evolva has transformed from an R&D-driven enterprise to a commercial company with a product-based revenue model. Its goal is to be cash break-even by FY23.